Clinical Outcomes Following Low-Dose Second-Generation “Ranger” Drug-Coated Balloon Angioplasty for Femoropopliteal Artery Disease
Our study demonstrated the true performance of Ranger DCB in real-world practice, with a very low rate of bail-out stenting and no use of atherectomy devices. In addition, it also elucidated morphologies associated with restenosis and the risk factors for restenosis after DCB. Freedom from re-stenosis and TLR at 1-year after Range DCB angioplasty was 84.5% and 91.5%. Two thirds of restenosis had a non-occlusive pattern, and independent predictors of restenosis were female gender, diabetes mellitus, no runoff, history of revascularization, lesion length ≥25 cm, and CTO.
Authors
- Yoshimitsu Soga (ORCID: https://orcid.org/0000-0003-1931-5769)
- Osamu Iida (ORCID: https://orcid.org/0000-0001-6829-7304)
- Daizo Kawasaki (ORCID: https://orcid.org/0000-0002-4413-6773)
- Kazuki Tobita (ORCID: https://orcid.org/0000-0002-1913-6894)
- Masahiko Fujihara (ORCID: https://orcid.org/0000-0002-7001-9220)
- Mitsuyoshi Takahara (ORCID: https://orcid.org/0000-0001-5105-041X)
Institutions
- Osaka Police Hospital (JP)
- Kishiwada Tokushukai Hospital (JP)
- Shonan Kamakura General Hospital (JP)
- Morinomiya Hospital (JP)
- Kokura Memorial Hospital (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Journal of Endovascular Therapy
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1177/15266028241292464
- Citations
- 6
- Primary Topic
- Peripheral Artery Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 3.44